首页> 外文期刊>Biotechnology Journal: Healthcare,Nutrition,Technology >Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4
【24h】

Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4

机译:设计UDP前体生物合成途径的一个分支可增强大肠杆菌O5:K4:H4中荚膜多糖的产生

获取原文
获取原文并翻译 | 示例
           

摘要

Escherichia coli K4 produces a capsule with a chemical structure that resembles chondroitin, a molecule with established chondro protective properties. The endogenous genes pgm and galU are involved in the biosynthesis of UDP-glucose which is a critical intermediate in carbohydrate metabolism and biochemical precursor of UDP-glucuronic acid. Together with UDP-N-acetylgalactosamine, UDP-glucuronic acid is used as sugar donor for capsule biosynthesis. The aim of the study was to evaluate how a change in the pathways leading to UDP-glucuronic acid biosynthesis affected capsular polysaccharide production. One additional copy of pgm and galU was introduced in E. coli K4 and in the previously described recombinant strain EcK4r3. A microbioreactor was used to analyse strain performance with parallel batch experiments, demonstrating increased polysaccharide concentrations and providing data that are comparable to those obtained in larger fermenters. Further experiments on a glutamine enriched medium showed an additional 45% increase of capsule production, maybe indicating the need to balance both branches leading to polymer biosynthesis in order to maximize yields. In the effort towards the establishment of a feasible bio-chondroitin production process this study provides information on how the availability of sugar precursors impacts polysaccharide biosynthesis in E. coli K4, a complex unexplored aspect of a multifaceted process.
机译:大肠杆菌K4产生的胶囊具有类似于软骨素的化学结构,而软骨素是具有确定的软骨保护特性的分子。内源基因pgm和galU参与UDP-葡萄糖的生物合成,UDP-葡萄糖是碳水化合物代谢和UDP-葡萄糖醛酸的生化前体的关键中间体。 UDP-葡萄糖醛酸与UDP-N-乙酰半乳糖胺一起用作胶囊生物合成的糖供体。该研究的目的是评估导致UDP-葡萄糖醛酸生物合成的途径变化如何影响荚膜多糖的产生。将另一拷贝的pgm和galU引入大肠杆菌K4和先前描述的重组菌株EcK4r3中。使用微生物反应器通过并行批处理实验分析菌株性能,证明了多糖浓度增加,并提供了与大型发酵罐中可比的数据。在富含谷氨酰胺的培养基上进行的进一步实验表明,胶囊产量增加了45%,这可能表明需要平衡导致聚合物生物合成的两个分支,以使产量最大化。在努力建立可行的软骨素生产工艺的过程中,本研究提供了有关糖前体的可用性如何影响大肠杆菌K4中多糖生物合成的信息,这是多方面过程中一个尚未探索的复杂方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号